MGIM
SGMO

M&G Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

M&G Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,734
Closed -$205 – 706
2021
Q3 		$205 Sell
22,734
-1,492
-6% -$14.7K ﹤0.01% 724
2021
Q2 		$291 Buy
+24,226
New +$274K ﹤0.01% 698

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

M&G Investment Management's SGMO Position: Q4 2021 in Review

M&G Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 22,734 shares — an estimated $205 sold.

M&G Investment Management first reported a position in SGMO in Q2 2021 and held it in 2 quarters. The position peaked at $291 in Q2 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • M&G Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 22,734 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $205.
  • M&G Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's SANGAMO THERAPEUTICS INC position peaked at $291 in Q2 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.